{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:07:03Z","timestamp":1779433623453,"version":"3.53.1"},"reference-count":33,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate maternal and fetal pregnancy outcomes of women with type 1 diabetes managed on continuous subcutaneous insulin infusion (CSII) compared with multiple daily insulin injections (MDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>Pregnancy outcomes were assessed retrospectively in women with type 1 diabetes who were patients of the Diabetes Clinic of North Karelia Hospital (Joensuu, Finland) between 2000 and 2012. The medical records of 72 women experiencing 135 pregnancies and data of their infants were retrospectively reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In total, 48 pregnancies were treated with CSII and 87 with MDI. Women on CSII treatment were older and had more diabetes complications compared with women on MDI. No significant differences in glycated hemoglobin (HbA1c) levels were observed between the CSII and MDI groups before or during pregnancy. Maternal or fetal outcomes did not differ between the treatment groups. However, among women with complicated diabetes, HbA1c levels were significantly lower in the CSII group until the second trimester (prepregnancy, 7.22% vs. 8.14%, respectively [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.034]; first trimester, 6.85% vs. 7.87% [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.001]; second trimester, 6.41% vs. 7.03% [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.029]) without an increased rate of maternal hypoglycemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pregnancy outcomes were similar regardless of insulin treatment modality. Although using an insulin pump did not result in improvement of pregnancy outcomes, it allowed for better glycemic control in pregnancies of women with complicated diabetes. Therefore, it is worth considering in high-risk T1DM pregnancies, especially if good glycemic control is not achieved otherwise.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/dia.2015.0165","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T12:48:44Z","timestamp":1445863724000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes"],"prefix":"10.1177","volume":"18","author":[{"given":"P\u00e4ivi","family":"Kek\u00e4l\u00e4inen","sequence":"first","affiliation":[{"name":"Hospital District of North Karelia","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Juuti","sequence":"additional","affiliation":[{"name":"Hospital District of North Karelia","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Walle","sequence":"additional","affiliation":[{"name":"Hospital District of North Karelia","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Laatikainen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland","place":["Finland"]},{"name":"Hospital District of North Karelia","place":["Finland"]},{"name":"National Institute for Health and Welfare","place":["Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-4-41"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050010"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.11.2990"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38043.583160.EE"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2281-7"},{"issue":"5","key":"e_1_3_3_7_2","first-page":"6","article-title":"ATLANTIC DIP: pregnancy outcomes for women with type 1 and type 2 diabetes","volume":"105","author":"Dunne FP","year":"2012","unstructured":"Dunne FP, , Avalos G, , Durkan M, et al.: ATLANTIC DIP: pregnancy outcomes for women with type 1 and type 2 diabetes. Ir Med J, 2012; 105(5 Suppl):6\u20139.","journal-title":"Ir Med J"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2627-9"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.864631"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00401047"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0244"},{"key":"e_1_3_3_12_2","first-page":"S1","article-title":"Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review","volume":"18","author":"Golden SH","year":"2012","unstructured":"Golden SH, , Sapir T: Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. J Manag Care Pharm, 2012; 18(6 Suppl):S1\u2013S17.","journal-title":"J Manag Care Pharm"},{"key":"e_1_3_3_13_2","first-page":"657","article-title":"Comparison of intensified traditional insulin therapy and micropump therapy in pregnant women with type 1 diabetes mellitus","volume":"77","author":"Botta RM","year":"1986","unstructured":"Botta RM, , Sinagra D, , Angelico M-C, et al.: Comparison of intensified traditional insulin therapy and micropump therapy in pregnant women with type 1 diabetes mellitus. Minerva Med, 1986; 77:657\u2013661.","journal-title":"Minerva Med"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000293680"},{"key":"e_1_3_3_15_2","first-page":"33","article-title":"Is continuous subcutaneous insulin infusion more effective than conventional insulin therapy in the treatment of pregnant diabetic women?","volume":"6","author":"Nosari I","year":"1993","unstructured":"Nosari I, , Maglio ML, , Lepore G, et al.: Is continuous subcutaneous insulin infusion more effective than conventional insulin therapy in the treatment of pregnant diabetic women?. Diabetes Nutr Metab, 1993; 6:33\u201337.","journal-title":"Diabetes Nutr Metab"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-003-0103-1"},{"key":"e_1_3_3_17_2","first-page":"339","article-title":"Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections","volume":"118","author":"Cypryk K","year":"2008","unstructured":"Cypryk K, , Kosi\u0144ski M, , Kami\u0144ska P, et al.: Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. Pol Arch Med Wewn, 2008; 118:339\u2013344.","journal-title":"Pol Arch Med Wewn"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0081"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/09513590903215540"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.914922"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.02.002"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-013-1027-6"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12027"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3163-6"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2013.02.032"},{"key":"e_1_3_3_26_2","first-page":"121","article-title":"Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy","volume":"12","author":"Carta Q","year":"1986","unstructured":"Carta Q, , Meriggi E, , Trossarelli GF, et al.: Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Diabete Metab, 1986; 12:121\u2013129.","journal-title":"Diabete Metab"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.06.007"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9020"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200503000-00049"},{"key":"e_1_3_3_30_2","unstructured":"V\u00e4\u00e4r\u00e4sm\u00e4ki M KaajaR Kr\u00f6ger J et al.: Timinonen S: Treatment of Diabetic During Pregnancy [in Finnish]. Finnish Diabetes Association. 2012. www.diabetes.fi\/files\/2169\/Diabeetikon_hoito_raskauden_aikana.pdf (accessed June11 2012)."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-007-0239-5"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0111"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.934274"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0450-4"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2015.0165","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2015.0165","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2015.0165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:27:33Z","timestamp":1779431253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2015.0165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1089\/dia.2015.0165"],"URL":"https:\/\/doi.org\/10.1089\/dia.2015.0165","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}